• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Introduction to 6-(methylsulfanyl)-1,3-benzothiazol-2-amine (CAS No. 50850-92-5)

6-(methylsulfanyl)-1,3-benzothiazol-2-amine, identified by the Chemical Abstracts Service Number (CAS No.) 50850-92-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the benzothiazole class, a structural motif widely recognized for its biological activity and utility in medicinal chemistry. The presence of a methylsulfanyl group at the 6-position and an amine substituent at the 2-position contributes to its unique chemical properties and potential applications.

The benzothiazole core is a fused ring system consisting of a benzene ring and a thiazole ring, which is known for its stability and ability to interact with biological targets. The methylsulfanyl group (-SCH?) introduces a polar, sulfur-rich moiety that can enhance solubility and binding affinity, while the amine group (-NH?) provides a site for further functionalization or interaction with biological molecules. These features make 6-(methylsulfanyl)-1,3-benzothiazol-2-amine a promising candidate for drug discovery and development.

In recent years, there has been a growing interest in benzothiazole derivatives due to their diverse pharmacological effects. Studies have shown that these compounds exhibit antimicrobial, anti-inflammatory, antiviral, and anticancer properties. The specific arrangement of functional groups in 6-(methylsulfanyl)-1,3-benzothiazol-2-amine may contribute to its potential as an intermediate in synthesizing novel therapeutic agents. Researchers have been exploring its structural analogs to identify more potent and selective bioactive molecules.

One of the most compelling aspects of 6-(methylsulfanyl)-1,3-benzothiazol-2-amine is its role as a building block in medicinal chemistry. The compound's versatility allows chemists to modify its structure in various ways, enabling the creation of libraries of derivatives with tailored properties. For instance, replacing the methylsulfanyl group with other sulfur-containing moieties or introducing additional heterocycles could lead to compounds with enhanced biological activity. This flexibility makes it an invaluable tool for drug designers seeking to develop innovative treatments for various diseases.

Recent advancements in computational chemistry have also facilitated the study of 6-(methylsulfanyl)-1,3-benzothiazol-2-amine. Molecular modeling techniques allow researchers to predict how this compound might interact with target proteins or enzymes, providing insights into its mechanism of action. Such simulations are crucial for optimizing drug design and improving the efficiency of experimental trials. By combining experimental data with computational predictions, scientists can accelerate the discovery process and bring new therapeutic options to patients more quickly.

The synthesis of 6-(methylsulfanyl)-1,3-benzothiazol-2-amine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include cyclization reactions followed by functional group transformations. The introduction of the methylsulfanyl group typically involves thiolation or nucleophilic substitution reactions, while the amine functionality can be incorporated through reductive amination or other methods. Each step must be carefully controlled to avoid side reactions that could compromise the final product's integrity.

In terms of applications, 6-(methylsulfanyl)-1,3-benzothiazol-2-amine has shown promise in preclinical studies as a precursor for developing novel therapeutics. Its structural features make it particularly interesting for targeting enzymes involved in inflammatory pathways or cancer metabolism. For example, derivatives of this compound have been investigated for their potential to inhibit kinases or modulate transcription factors that play key roles in disease progression. These findings highlight its significance as a scaffold for drug development.

The pharmaceutical industry continues to explore new ways to leverage benzothiazole derivatives like 6-(methylsulfanyl)-1,3-benzothiazol-2-amine. Collaborative efforts between academic researchers and industry scientists are driving innovation in this area. By sharing knowledge and resources, these partnerships can accelerate the translation of laboratory discoveries into clinical applications. This synergy is essential for addressing unmet medical needs and improving patient outcomes worldwide.

As research progresses, the understanding of how 6-(methylsulfanyl)-1,3-benzothiazol-2-amine interacts with biological systems will continue to evolve. New techniques and methodologies will further refine our ability to study this compound and its derivatives at both molecular and cellular levels. This ongoing investigation not only advances our fundamental knowledge but also opens up new avenues for therapeutic intervention. The future holds great potential for this versatile benzothiazole derivative as it continues to be explored in various scientific contexts.

• 326-45-4(6-(trifluoromethyl)sulfanyl-1,3-benzothiazol-2-amine)
• 17557-67-4(6-methanesulfonyl-1,3-benzothiazol-2-amine)
• 71680-87-0(2-Benzothiazolamine,6-(ethylthio)-)
• 16162-28-0(DABBT)
• 2789-24-4(Benzo[1,2-d:5,4-d']bisthiazole-2,6-diamine)
• 136-95-8(Benzo[d]thiazol-2-amine)
• 193423-34-6( )
• 7170-77-6([(2-amino-1,3-benzothiazol-6-yl)sulfanyl]formonitrile)
• 84293-42-5(2-Aminobenzothiazole)
• 21615-35-0(Thiocyanic acid,2-amino-5-methyl-6-benzothiazolyl ester)